206 results
Page 4 of 11
8-K
EX-4.2
6oc6giak9yvj8s
2 Mar 20
Vaxart Announces $10.0 Million Registered Direct Offering Priced At-the-Market
2:48pm
424B5
utin3j6xpv7f
2 Mar 20
Prospectus supplement for primary offering
11:44am
424B4
1pi5r kevrm10pa4xoy6
27 Sep 19
Prospectus supplement with pricing info
4:32pm
8-K
EX-99.1
d5s1fa7zs
9 May 19
Vaxart Announces First Quarter 2019 Financial Results
4:03pm
8-K
EX-10.1
n8qknt60
24 Apr 19
Departure of Directors or Certain Officers
4:00pm
424B4
5dpr8jk 1xc
10 Apr 19
Prospectus supplement with pricing info
5:07pm
8-K
EX-10.3
uh9hexkm1jr5cu
20 Mar 19
Entry into a Material Definitive Agreement
1:47pm
424B5
uxme4
20 Mar 19
Prospectus supplement for primary offering
1:45pm